These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33833755)

  • 1. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients.
    Schwarz T; Heiss K; Mahendran Y; Casilag F; Kurth F; Sander LE; Wendtner CM; Hoechstetter MA; Müller MA; Sekul R; Drosten C; Stadler V; Corman VM
    Front Immunol; 2021; 12():629185. PubMed ID: 33833755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients.
    Cheng L; Zhang X; Chen Y; Wang D; Zhang D; Yan S; Wang H; Xiao M; Liang T; Li H; Xu M; Hou X; Dai J; Wu X; Li M; Lu M; Wu D; Tian R; Zhao J; Zhang Y; Cao W; Wang J; Yan X; Zhou X; Liu Z; Xu Y; He F; Li Y; Yu X; Zhang S
    Signal Transduct Target Ther; 2021 Aug; 6(1):304. PubMed ID: 34404759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19.
    Ravichandran S; Tang J; Grubbs G; Lee Y; Pourhashemi S; Hussaini L; Lapp SA; Jerris RC; Singh V; Chahroudi A; Anderson EJ; Rostad CA; Khurana S
    Nat Immunol; 2021 Nov; 22(11):1452-1464. PubMed ID: 34611361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.
    Mazzini L; Martinuzzi D; Hyseni I; Benincasa L; Molesti E; Casa E; Lapini G; Piu P; Trombetta CM; Marchi S; Razzano I; Manenti A; Montomoli E
    J Immunol Methods; 2021 Feb; 489():112937. PubMed ID: 33253698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term monitoring of the development and extinction of IgA and IgG responses to SARS-CoV-2 infection.
    Ivanov A; Semenova E
    J Med Virol; 2021 Oct; 93(10):5953-5960. PubMed ID: 34185312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral Immune Response Profile of COVID-19 Reveals Severity and Variant-Specific Epitopes: Lessons from SARS-CoV-2 Peptide Microarray.
    Acharjee A; Ray A; Salkar A; Bihani S; Tuckley C; Shastri J; Agrawal S; Duttagupta S; Srivastava S
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort.
    Smith M; Abdesselem HB; Mullins M; Tan TM; Nel AJM; Al-Nesf MAY; Bensmail I; Majbour NK; Vaikath NN; Naik A; Ouararhni K; Mohamed-Ali V; Al-Maadheed M; Schell DT; Baros-Steyl SS; Anuar ND; Ismail NH; Morris PE; Mamat RNR; Rosli NSM; Anwar A; Ellan K; Zain RM; Burgers WA; Mayne ES; El-Agnaf OMA; Blackburn JM
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal and proteome-wide analyses of antibodies in COVID-19 patients reveal features of the humoral immune response to SARS-CoV-2.
    Wang J; Yang Y; Liang T; Yang N; Li T; Zheng C; Ning N; Luo D; Yang X; He Z; Yang G; Li B; Gao J; Yu W; Gong S; Huang Y; Li J; Wang H; Zhang H; Zhang T; Li P; Li Y; Dai J; Zhang X; Li B; Yu X; Wang H
    J Adv Res; 2022 Mar; 37():209-219. PubMed ID: 35475278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The landscape of antibody binding in SARS-CoV-2 infection.
    Heffron AS; McIlwain SJ; Amjadi MF; Baker DA; Khullar S; Armbrust T; Halfmann PJ; Kawaoka Y; Sethi AK; Palmenberg AC; Shelef MA; O'Connor DH; Ong IM
    PLoS Biol; 2021 Jun; 19(6):e3001265. PubMed ID: 34143766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients.
    Frasca D; Reidy L; Cray C; Diaz A; Romero M; Kahl K; Blomberg BB
    PLoS One; 2021; 16(3):e0245424. PubMed ID: 33760825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection.
    Russell MW; Moldoveanu Z; Ogra PL; Mestecky J
    Front Immunol; 2020; 11():611337. PubMed ID: 33329607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients.
    Oja AE; Saris A; Ghandour CA; Kragten NAM; Hogema BM; Nossent EJ; Heunks LMA; Cuvalay S; Slot E; Linty F; Swaneveld FH; Vrielink H; Vidarsson G; Rispens T; van der Schoot E; van Lier RAW; Ten Brinke A; Hombrink P
    Eur J Immunol; 2020 Dec; 50(12):1998-2012. PubMed ID: 33073359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19.
    Wu J; Liang B; Chen C; Wang H; Fang Y; Shen S; Yang X; Wang B; Chen L; Chen Q; Wu Y; Liu J; Yang X; Li W; Zhu B; Zhou W; Wang H; Li S; Lu S; Liu D; Li H; Krawczyk A; Lu M; Yang D; Deng F; Dittmer U; Trilling M; Zheng X
    Nat Commun; 2021 Mar; 12(1):1813. PubMed ID: 33753738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
    Carsetti R; Zaffina S; Piano Mortari E; Terreri S; Corrente F; Capponi C; Palomba P; Mirabella M; Cascioli S; Palange P; Cuccaro I; Milito C; Zumla A; Maeurer M; Camisa V; Vinci MR; Santoro A; Cimini E; Marchioni L; Nicastri E; Palmieri F; Agrati C; Ippolito G; Porzio O; Concato C; Onetti Muda A; Raponi M; Quintarelli C; Quinti I; Locatelli F
    Front Immunol; 2020; 11():610300. PubMed ID: 33391280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals.
    Yoshida S; Ono C; Hayashi H; Fukumoto S; Shiraishi S; Tomono K; Arase H; Matsuura Y; Nakagami H
    Sci Rep; 2021 Mar; 11(1):5934. PubMed ID: 33723294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.
    Sasisekharan V; Pentakota N; Jayaraman A; Tharakaraman K; Wogan GN; Narayanasami U
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33446512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.